XML 49 R33.htm IDEA: XBRL DOCUMENT
v3.24.1

Stockholders’ Equity (Deficit) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stockholders’ Equity (Deficit) [Abstract] |
Schedule of Outstanding and Exercisable Warrants and Related Transactions | As of December 31, 2023, the following table summarizes the status of our outstanding and exercisable warrants and related transactions since December 31, 2021 (in thousands, except weighted average exercise price and weighted average remaining contractual life data):
|  | Warrants outstanding and exercisable |
|  | Warrants |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in Years) |
Balance, December 31, 2021 |  |  | 103 |  |  | $ | 76.19 |  |  | $ | — |  |  |  | 8.3 |
Granted |  |  | 436 |  |  |  | 0.14 |  |  |  |  |  |  |  |  |
Expired |  |  | (3 | ) |  |  | 341.5 |  |  |  |  |  |  |  |  |
Balance, December 31, 2022 |  |  | 536 |  |  |  | 13.10 |  |  |  | 2,427 |  |  |  | 9.3 |
Exercised |  |  | (435 | ) |  |  | 0.01 |  |  |  | (2,270 | ) |  |  |  |
Expired |  |  | (2 | ) |  |  | 0.89 |  |  |  |  |  |  |  |  |
Balance, December 31, 2023 |  |  | 99 |  |  | $ | 66.61 |  |  | $ | 1,793 |  |  |  | 6.5 |
Schedule of Stock Options Activity | The following table summarizes the status of our outstanding and exercisable options and related transactions (each adjusted to account for the Reverse Stock Split) since December 31, 2022 (in thousands, except weighed average exercise price and weighted average remaining contractual life data):
|  | Outstanding |  |  | Exercisable |
|  | Options Awards |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in Years) |  |  | Options Awards |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in Years) |
As of January 1, 2022 |  |  | 353 |  |  | $ | 225.98 |  |  |  | — |  |  |  | 3.8 |  |  |  | 336 |  |  |  | 230.93 |  |  | $ | — |  |  |  | 3.6 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Cancelled/Forfeited |  |  | (4 | ) |  |  | 94.99 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (177 | ) |  |  | 226.56 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
As of December 31, 2022 |  |  | 172 |  |  |  | 228.28 |  |  |  | — |  |  |  | 3.6 |  |  |  | 170 |  |  |  | 229.43 |  |  |  | — |  |  |  | 3.6 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Cancelled/Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | (100 | ) |  |  | 206.15 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
As of December 31, 2023 |  |  | 72 |  |  | $ | 258.55 |  |  | $ | — |  |  |  | 3.0 |  |  |  | 73 |  |  |  | 258.46 |  |  | $ | — |  |  |  | 3.0 |
Schedule of the Status of our Unvested and Related Transactions | The following table summarizes the status of our RSUs and related transactions (each adjusted to account for the Reverse Stock Split) (in thousands, except weighed average grant date fair value):
|  | RSUs awards outstanding |
|  | RSUs |  |  | Weighted Average Grant Date Fair Value |  |  | Aggregate Intrinsic Value |
Balance, January 1, 2022 |  |  | 272 |  |  | $ | 58.00 |  |  | $ | 4,890.00 |
Granted |  |  | 170 |  |  |  | 16.05 |  |  |  |  |
Vested |  |  | (327 | ) |  |  | 48.20 |  |  |  |  |
Cancelled/Forfeited |  |  | (58 | ) |  |  | 37 |  |  |  |  |
Balance, as of December 31, 2022 |  |  | 57 |  |  |  | 14.57 |  |  |  | 318.63 |
Granted |  |  | 163 |  |  |  | 4.82 |  |  |  | — |
Vested |  |  | (180 | ) |  |  | 6.83 |  |  |  | — |
Cancelled/Forfeited |  |  | — |  |  |  | — |  |  |  | — |
Balance, as of December 31, 2023 |  |  | 40 |  |  | $ | 9.67 |  |  | $ | 89.6 |
The following table summarizes the status of our PSUs and related transactions for each for the following years (each adjusted to account for the Reverse Stock Split) (in thousands, except weighed average grant date fair value):
|  | PSUs |  |  | Weighted Average Grant Date Fair Value |  |  | Aggregate Intrinsic Value |
Balance, December 31, 2021 |  |  | 164 |  |  | $ | 51.50 |  |  | $ | 2,953 |
Granted |  |  | 63 |  |  |  | 34.50 |  |  |  |  |
Vested and settled |  |  | (133 | ) |  |  | 47.12 |  |  |  | (2,382.98 | )
Cancelled/Forfeited |  |  | (75 | ) |  |  | (44.85 | ) |  |  |  |
Unvested, as of January 1, 2023 |  |  | 19 |  |  |  | 52.15 |  |  |  | 107.55 |
Granted |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | (5 | ) |  |  | 56.05 |  |  |  | (10.72 | )
Cancelled/Forfeited |  |  | — |  |  |  | — |  |  |  | — |
Unvested, as of December 31, 2023 |  |  | 14 |  |  | $ | 50.87 |  |  | $ | 33 |

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for warrants that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of warrants that were granted, exercised, forfeited, and expired during the year. + References No definition available. + Details
Name: | txmd_ScheduleOfWarrantRollForwardTableTextBlock
Namespace Prefix: | txmd_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in restricted stock units (RSUs). + References No definition available. + Details
Name: | us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration